Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes.

被引：0
|
作者：
Urrutia, Samuel
Sasaki, Koji
Kantarjian, Hagop M.
Jabbour, Elias
Chien, Kelly Sharon
Hammond, Danielle
Bueso-Ramos, Carlos E.
Khoury, Joseph
Patel, Keyur P.
Montalban-Bravo, Guillermo
Wei, Yue
Colla, Simona
Short, Nicholas James
Daver, Naval Guastad
Borthakur, Gautam
Kadia, Tapan M.
Pierce, Sherry
Wierda, William G.
Garcia-Manero, Guillermo
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6567
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Etiologic factors of myelodysplastic syndromes.
    Nisse, C
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 539 - 544
  • [32] Prognostic classification in myelodysplastic syndromes.
    Sanz, GF
    Morel, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 617 - 626
  • [33] Editorial. Myelodysplastic syndromes.
    Fenaux, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 537 - 538
  • [34] Treatment strategy for myelodysplastic syndromes.
    Fenaux, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 668 - 670
  • [35] Mechanisms of Disease: Myelodysplastic Syndromes.
    Tefferi, Ayalew
    Vardiman, James W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (19): : 1872 - 1885
  • [36] Psychological distress in myelodysplastic syndromes.
    Vallely, Jaxon
    Troy, Jesse D.
    Locke, Susan C.
    LeBlanc, Thomas William
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Evaluation of cellular proliferation markers in patients with myelodysplastic syndromes.
    Ismail, SO
    Mutema, G
    Perrotta, G
    Hornback, B
    Wibowo, A
    Mazzella, F
    KowalVern, A
    Schumacher, HR
    BLOOD, 1997, 90 (10) : 4040 - 4040
  • [38] Paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes.
    Iwanaga, M
    Furukawa, K
    Amenomori, T
    Mori, H
    Nakamura, H
    Fuchigami, K
    Kamihira, S
    Nakakuma, H
    Tomonaga, M
    BLOOD, 1997, 90 (10) : 2708 - 2708
  • [39] Intensive chemotherapy in myelodysplastic syndromes.
    Dombret, H
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 627 - 635
  • [40] Progress in myelodysplastic syndromes. Introduction
    Kelaidi, Charikleia
    Fenaux, Pierre
    HEMATOLOGIE, 2006, 12 : 2 - 2
12345